Myalepta (Metreleptin): New Hope For Patients With Lipodystrophy
Myalepta (generic: metreleptin), the first approved leptin replacement therapy, is offering new hope for these…
Articles
Luxturna Gene Therapy: New Hope For Patients With Hereditary Vision Loss
Luxturna (generic name: voretigene neparvovec-rzyl) is the first gene therapy approved by the U.S. Food…
Novel Drug Lumizyme: A New Light For Rare Disease Treatment
In exciting news for the healthcare sector, an innovative drug called Lumizyme is becoming the…
Quviviq: A New Ray Of Hope In Insomnia Treatment
Quviviq (dazodalant) is an innovative insomnia treatment that is unique in its novel mechanism of…
Folotyn (Pralatrexate) Receives FDA Approval Global Update
Folotyn (generic name: Pralatrexate), the first drug approved by the U.S. Food and Drug Administration…
Rezivertinib Mesylate Capsules: A New Hope For NSCLC Patients
March 20, 2025 – A breakthrough in cancer treatment has emerged with the approval and…
Tabrecta Approval Offers New Hope For Non-Small Cell Lung Cancer Patients
May 6, 2020- The U.S. Food and Drug Administration (FDA) today approved Tabrecta (capmatinib) for…
Brineura Promises To Prolong Quality Of Life In CLN2 Patients
Brineura® (cerliponase alfa), the only FDA-approved enzyme replacement therapy for late-infantile neuronal ceroid lipofuscinosis type 2…
Parsabiv (Etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism (SHPT) In Dialysis Patients
Parsabiv (Etelcalcetide), an innovative calcimimetic, was recently formally approved for the treatment of secondary hyperparathyroidism…
Retevmo (Selpercatinib) Achieves Positive Results in Phase III Clinical Trial
August 5, 2023 – Eli Lilly and Company (Eli Lilly) announced that its RET inhibitor…